Sunitinib: From Rational Design to Clinical Efficacy
Sunitinib (SU011248) is an oral small molecular tyrosine kinase inhibitor that exhibits potent antiangiogenic and antitumor activity. Tyrosine kinase inhibitors such as SU6668 a...
Publications
2 shownRandomized Phase III Study of Exatecan and Gemcitabine Compared With Gemcitabine Alone in Untreated Advanced Pancreatic Cancer
Purpose Exatecan mesylate is a hexacyclic, water-soluble, topoisomerase-1 inhibitor. Exatecan has single-agent and combination activity with gemcitabine in advanced pancreatic c...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 1,136
- Institution
- University of Colorado Anschutz Medical Campus
External Links
Identifiers
- ORCID
- 0000-0002-8103-1620
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.